Health
Balancing Hope and Proof: Investigational Products During the COVID-19 Pandemic
On October 2, 2020, the White House announced that President Trump received an investigational antibody cocktail (REGN-COV2) for COVID-19 made by Regeneron Pharmaceuticals, Inc